Anti-GM2 IgM antibodies: clinical correlates and reactivity with a human neuroblastoma cell line

[1]  G. Scarlato,et al.  Expression of glycosylated recombinant human myelin-associated glycoprotein on a neuroblastoma cell line and its reactivity with HNK-1 but not human anti-MAG antibodies , 1998, Neuroscience Letters.

[2]  R. Pedotti,et al.  Clinical correlate and fine specificity of anti-GQ1b antibodies in peripheral neuropathy , 1998, Journal of the Neurological Sciences.

[3]  N. Yuki,et al.  Acute cytomegalovirus infection and IgM anti-GM2 antibody , 1998, Journal of the Neurological Sciences.

[4]  K. David,et al.  Expression of a 260 kDa neuroblastoma surface antigen, the target of cytotoxic natural human IgM: correlation to MYCN amplification and effects of retinoic acid. , 1997, European journal of cancer.

[5]  B. Jacobs,et al.  Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[6]  N. Yuki,et al.  Antibody to Ga1NAc-GD1a and Ga1NAc-GM1b in Guillain—Barré syndrome subsequent to Campylobacter jejuni enteritis , 1996, Journal of Neuroimmunology.

[7]  M. Ogino,et al.  Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection , 1996, Journal of Neuroimmunology.

[8]  E. Nobile‐Orazio Multifocal motor neuropathy. , 1996, Journal of neuroimmunology.

[9]  K. David,et al.  Normal human serum contains a natural IgM antibody cytotoxic for human neuroblastoma cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Barbieri,et al.  Anti‐GD1a ganglioside antibodies in peripheral motor syndromes , 1996, Annals of neurology.

[11]  H. Willison,et al.  Anti-GM1 Ganglioside Antibodies Cloned from Autoimmune Neuropathy Patients Show Diverse Binding Patterns in the Rodent Nervous System , 1996, Journal of neuropathology and experimental neurology.

[12]  T. Miyatake,et al.  Ganglioside characterization of a cell line displaying motor neuron-like phenotype: GM2 as a possible major ganglioside in motor neurons , 1995, Journal of the Neurological Sciences.

[13]  A. Pestronk,et al.  Chronic motor neuropathies: Diagnosis, therapy, and pathogenesis , 1995, Annals of neurology.

[14]  H. Willison Antiglycolipid antibodies in peripheral neuropathy: fact or fiction? , 1994, Journal of neurology, neurosurgery, and psychiatry.

[15]  N. Baumann,et al.  Reactivity of a human monoclonal anti-GM1 and anti-GD1b IgM antibody with human neurons in cultures , 1993, Journal of Neuroimmunology.

[16]  Ruixiang Li,et al.  Alteration of Neuroblastoma Ganglioside Metabolism by Retinoic Acid , 1992, Journal of neurochemistry.

[17]  T. Miyatake,et al.  IgM anti-(GalNAc beta 1-4 Gal[3-2 alpha NeuAc] beta 1-) antibody-mediated cytotoxicity in a patient with amyotrophic lateral sclerosis-like disorder. , 1992, Muscle & nerve.

[18]  A. Lugaresi,et al.  Patterns of reactivity of human anti‐GM1 antibodies with spinal cord and motor neurons , 1992, Annals of neurology.

[19]  M. Dalakas,et al.  Sensory neuropathy associated with monoclonal immunoglobulin M to GD1b ganglioside , 1992, Annals of neurology.

[20]  M. Kaji,et al.  Changes in the ganglioside composition of human neuroblastoma cells under different growth conditions , 1991, International journal of cancer.

[21]  G. Legname,et al.  Anti‐GM1 IgM antibodies in motor neuron disease and neuropathy , 1990, Neurology.

[22]  G. Legname,et al.  Motor neuron disease in a patient with a monoclonal IgMk directed against GM1, GD1b, and high‐molecular‐weight neural‐specific glycoproteins , 1990, Annals of neurology.

[23]  L. Berg,et al.  The spectrum of neurologic disease associated with anti‐GM1 antibodies , 1990, Neurology.

[24]  E. Scarpini,et al.  Quantitative assessment of class II molecules in normal and pathological nerves. Immunocytochemical studies in vivo and in tissue culture. , 1990, Brain : a journal of neurology.

[25]  M. Routbort,et al.  Polyclonal IgM anti‐GM1 ganglioside antibody in patients with motor neuron disease and variants , 1990, Annals of neurology.

[26]  A. Pestronk,et al.  Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies , 1990, Annals of neurology.

[27]  R. Liem,et al.  Autoantigens in human neuroblastoma cells , 1990, Journal of Neuroimmunology.

[28]  S. Lipton,et al.  A syndrome of asymmetric limb weakness with motor conduction block , 1990, Neurology.

[29]  S. Kusunoki,et al.  Motor dominant neuropathy and IgM paraproteinemia: the IgM M-protein binds to specific gangliosides , 1989, Journal of Neuroimmunology.

[30]  M. Dalakas,et al.  Identification and Characterization of Gangliosides Reacting with IgM Paraproteins in Three Patients with Neuropathy Associated with Biclonal Gammopathy , 1988, Journal of neurochemistry.

[31]  Denise,et al.  Gangliosides GM2, IV4GalNAcGM1b, and IV4GalNAcGC1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy. , 1988, The Journal of biological chemistry.

[32]  R. Nemni,et al.  Immunofluorescence study of patients with neuropathy and IgM M proteins , 1985, Annals of neurology.

[33]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[34]  B. Spengler,et al.  Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. , 1973, Cancer research.

[35]  F. Bonali,et al.  A new procedure for the extraction, purification and fractionation of brain gangliosides. , 1973, Biochimica et biophysica acta.

[36]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[37]  N. Yuki Anti-ganglioside antibody and neuropathy: review of our research. , 1998, Journal of the peripheral nervous system : JPNS.

[38]  D. Cornblath,et al.  Assessment of current diagnostic criteria for Guillain‐Barré syndrome , 1990, Annals of neurology.